Boditech Med Inc. (KOSDAQ:206640)
14,080
+30 (0.21%)
Oct 10, 2025, 3:30 PM KST
Boditech Med Market Cap
Boditech Med has a market cap or net worth of 306.71 billion as of October 10, 2025. Its market cap has decreased by -20.79% in one year.
Market Cap
306.71B
Enterprise Value
270.24B
Revenue
149.40B
Ranking
n/a
PE Ratio
12.05
Stock Price
14,080.00
Market Cap Chart
Since September 1, 2015, Boditech Med's market cap has increased from 28.15B to 306.71B, an increase of 989.47%. That is a compound annual growth rate of 26.70%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 2, 2025 | 306.05B | -17.01% |
Dec 30, 2024 | 368.76B | -18.12% |
Dec 28, 2023 | 450.36B | 100.01% |
Dec 29, 2022 | 225.17B | -41.09% |
Dec 30, 2021 | 382.21B | -29.94% |
Dec 30, 2020 | 545.55B | 146.19% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Biologics | 72.17T |
Celltrion | 38.64T |
ALTEOGEN | 25.22T |
Yuhan | 8,969.60B |
SK Biopharmaceuticals | 8,136.75B |
Peptron | 6,866.96B |
PharmaResearch | 5,631.19B |
LigaChem Biosciences | 5,545.53B |